SOPHARMA AD: Consolidated financial report of Sopharma Group for the first half of 2018

2018-08-29 12:35

publikacja
2018-08-29 12:35

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załącznikw:
Consolidated_financial_report_of_Sopharma_Group_for_the_first_half_of_2018.zip (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		73	/	2018
Date of issue:	2018-08-29
Short name of the issuer
SOPHARMA AD
Subject
Consolidated financial report of Sopharma Group for the first half of 2018
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
1. Financial report according to IFRS as at 30 June 2018 2. Notes to the financial report as at 30 June 2018 3. Management report as at 30 June 2018 4. Insider information as at 30 June 2018 5. Additional information as at 30 June 2018 6. Financial report according to BFCS standards as at 30 June 2018 7. Annex 9 as at 30 June 2018 8. Declaration as at 30 June 2018
Annexes
File			Description
Consolidated financial report of Sopharma Group for the first half of 2018.zipConsolidated financial report of Sopharma Group for the first half of 2018.zip			Consolidated financial report of Sopharma Group for the first half of 2018

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2018-08-29	Ognian Donev	Executive director

Ważne linki